You searched for lung cancer | Page 72 of 153

OncoHost Launches NSCLC Test in the U.S.

OncoHost, a diagnostics company centered on predictive biomarker development patient care, launched its non-small lung cancer (NSCLC) test.

The liquid biopsy ctDx FIRST test is FDA approved as a companion diagnostic for advanced non-small cell lung cancer (NSCLC) patients.

Researchers developed a novel AI algorithm to classify lung cancer subtype based on lung tissue images from resected tumors.

Posted by Toni Mitchell | Sep 14, 2021 | Lung Cancer |

A recent report showed less than half of community oncologists used biomarker testing for lung cancer — compared to 73% of academic clinicians.

The companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients with HER2 mutations.